Quality of Life Through Patient-Reported Experience Integration With Longitudinal Imaging Care

Abstract

The integration of patient-reported experience measures (PREMs) with longitudinal imaging care represents a paradigm shift in the management of chronic diseases, providing a holistic view of patient wellness and guiding personalized therapeutic strategies. By aligning subjective patient feedback with objective imaging findings over time, healthcare providers can optimize clinical outcomes, enhance patient satisfaction, and facilitate shared decision-making. This review synthesizes current evidence on the clinical utility, methodological considerations, and practical implementation of combined PREM-imaging frameworks, highlighting their impact on quality of life, disease monitoring, and emerging guideline recommendations for doctors and healthcare professionals.

Introduction

Recent advances in medical practice emphasize the centrality of patient-centered care, particularly in chronic and complex diseases where longitudinal monitoring is essential. The integration of patient-reported experience measures (PREMs) with longitudinal imaging care offers a comprehensive approach to evaluating treatment efficacy, disease progression, and overall quality of life. PREMs capture subjective aspects of care, including emotional well-being, satisfaction, and perceived health outcomes, while imaging provides objective data on anatomical and functional changes. When combined, these tools support dynamic, responsive clinical decision-making and align treatment trajectories with patient priorities.

Epidemiology / Disease Burden

Chronic diseases such as cancer, inflammatory disorders, and cardiovascular conditions account for a substantial global disease burden and require ongoing assessment to monitor progression and response to therapy. Imaging modalities ranging from MRI and CT to ultrasound and PET are routinely employed for diagnosis and surveillance. However, traditional outcome measures often fail to capture the psychosocial and experiential dimensions of patient health. As a result, suboptimal quality of life (QoL) persists despite advances in diagnostic imaging. Integrating PREMs addresses this gap, providing epidemiological insight into the lived experience of affected populations and identifying unmet needs that may not be apparent through imaging alone.

Pathophysiology

Understanding the interplay between disease pathophysiology and patient experience is critical. For example, in oncology, tumor burden and anatomical changes visualized on imaging may correlate with physical symptoms, but fail to reflect fatigue, anxiety, or social functioning elements captured by PREMs. Similarly, inflammatory and degenerative diseases often yield imaging findings that precede or lag behind clinical symptoms. Longitudinal integration allows for the mapping of pathophysiological changes against experiential data, uncovering mechanisms by which disease processes affect QoL and guiding targeted interventions to address both physiological and psychosocial dimensions.

Risk Factors

Risk stratification in chronic diseases increasingly incorporates both biological and experiential factors. Traditional risk factors such as age, comorbidities, and genetic predispositions are complemented by patient-reported barriers, including healthcare accessibility, treatment adherence, and psychological distress. By systematically collecting PREMs alongside imaging, clinicians can identify at-risk subgroups for poor outcomes, such as those with high symptom burden but minimal imaging progression, or conversely, those with worsening imaging and stable subjective status. This dual assessment informs proactive care strategies, risk mitigation, and resource allocation.

Clinical Features

Clinical presentation in chronic diseases is heterogeneous, encompassing physical, emotional, and social domains. Imaging findings may elucidate the anatomical or functional basis for symptoms such as pain, dyspnea, or neurological deficits, while PREMs provide insight into fatigue, mood disturbances, and overall well-being. For instance, in multiple sclerosis, lesion load on MRI may not fully explain cognitive impairment or reduced life satisfaction. Mapping clinical features across both domains enables a more nuanced understanding of disease impact, facilitating tailored symptom management and rehabilitation interventions.

Diagnosis

Diagnostic pathways increasingly recognize the value of integrating patient experiences to complement imaging criteria. While imaging remains indispensable for confirming structural pathology, PREMs can flag early functional decline or complications not immediately apparent on scans. In rheumatology, for example, patient-reported pain and function scores are now incorporated into composite disease activity indices alongside imaging findings, improving diagnostic accuracy and timeliness of intervention. This holistic diagnostic approach reduces misclassification, enhances patient trust, and supports shared understanding of disease status.

Treatment & Management

Personalized treatment planning is optimized by synthesizing imaging data with patient-reported experiences. Imaging guides the selection and monitoring of therapies such as targeted agents, surgery, or radiotherapy while PREMs inform adjustments based on tolerability, lifestyle preferences, and psychosocial support needs. Longitudinal tracking enables real-time assessment of treatment impact on both anatomical targets and quality of life. For example, in oncology, integrating PREMs has been shown to improve symptom management, reduce hospitalizations, and promote adherence. Coordinated multidisciplinary care teams leverage these insights to deliver holistic, patient-centered management.

Recent Advances / Emerging Therapies

Emerging technologies facilitate seamless integration of PREMs with imaging platforms. Digital health tools, such as mobile apps and patient portals, enable continuous collection of experiential data, while artificial intelligence algorithms correlate these inputs with imaging trajectories. Recent trials in oncology and neurology demonstrate that real-time PREM feedback can trigger early intervention, prevent complications, and enhance patient engagement. Furthermore, machine learning approaches are being developed to predict QoL outcomes based on combined imaging and experiential datasets, supporting precision medicine and proactive care models.

Guideline Recommendations

Leading clinical guidelines now endorse the routine collection of PREMs in conjunction with imaging for chronic disease management. Organizations such as the American College of Radiology and European Society for Medical Oncology advocate for structured integration of patient-reported data into clinical workflows. Recommendations include establishing standardized PREM instruments, integrating them with electronic health records, and ensuring their use in longitudinal follow-up. These guidelines emphasize interdisciplinary collaboration and continuous quality improvement, with the goal of optimizing both clinical outcomes and patient experience.

Conclusion

The integration of patient-reported experience measures with longitudinal imaging care represents a transformative advance in chronic disease management. By capturing both the objective and subjective dimensions of health, clinicians are empowered to deliver more precise, responsive, and patient-centered care. Ongoing research and innovation will further refine these approaches, ensuring that quality of life is prioritized alongside traditional clinical endpoints. Healthcare professionals are encouraged to adopt integrated PREM-imaging frameworks to enhance outcomes, foster patient engagement, and meet evolving standards of care in the modern era.